Ambey Laboratories IPO Sees Listing Gain of 25% on NSE SME Debut

Byfinmoneydesk
July 11, 2024

Ambey Laboratories IPO Sees Listing Gain of 25% on NSE SME Debut

Ambey Laboratories made a strong market entry today after listing at Rs 85 a piece on the NSE SME Platform an impressive listing gain of 25% over the IPO issue price of Rs 68. Listing reflects the strong investor confidence in the company’s future growth and prospects.

Recently Ambey Laboratories, conducted a highly successful IPO from July 4 to July 8 with QIB’s subscribing 61.90 times, Non-Institutional Investors 324.22 times, and Retail Investors 195.06 times their respective reserved portions, indicating strong confidence of investor’s among all the categories.

Ambey Laboratories Limited specialises in manufacturing “2, 4-D base chemicals” used in agrochemicals. Located in Rajasthan, India, the company adheres to ISO 9001:2015 and ISO 14001:2015 standards and complies with the RoHS Directive. They also produce home hygiene products such as cleaners, repellents, hand wash, and sanitizers.

The main goal of Ambey Laboratories Limited IPO offering was, for meeting increased working capital needs and for general corporate purposes such as enhancing marketing capabilities and strategic initiatives.

English IPO SME IPO

finmoneydesk

Disclaimer:This is not an investment advisory. The article above is for information purposes only. Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, goal, time frame, risk and reward balance, and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs. The performance and returns of any investment portfolio can neither be predicted nor guaranteed.